47.69
price down icon2.03%   -0.99
pre-market  Vorhandelsmarkt:  47.98   0.29   +0.61%
loading

Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
40.12%
80.14
57.19 48.91 49.80 37.34
Operating Income/Loss
40.12%
-80.14
-57.19 -48.91 -49.80 -37.34
Nonoperating Income/Loss
34.36%
3.61
5.50 5.49 3.169 3.635
Income/Loss From Continuing Operations Before Tax
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Income/Loss From Continuing Operations After Tax
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Net Income/Loss
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
63.79
63.67 1.7888 54.90 54.73
Diluted Average Shares
0.18%
63.79
63.67 1.7888 54.90 54.73
Basic Earnings Per Share
48.15%
-1.20
-0.81 -0.72 -0.85 -0.62
Diluted Earnings Per Share
48.15%
-1.20
-0.81 -0.72 -0.85 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Kapitalisierung:     |  Volumen (24h):